This content is from: Premium Mergers Boost David Tepper’s Appaloosa Tepper’s fund and other hedge funds are benefiting from this week’s deals to acquire Caesars and Allergan. By Stephen Taub June 25, 2019
This content is from: Portfolio Why Popular Investments Are Doomed to Underperform An analysis of merger-arbitrage hedge funds finds that high capital inflows lead managers to compete away potential alpha. By Amy Whyte October 18, 2019
This content is from: Corner Office M&A Might Not Fix the Industry’s Problems, but Asset Manager Mergers Are Barreling Ahead Asset and wealth managers are racing to consolidate, completing double the number of transactions in the second quarter compared to the year before. By Julie Segal July 25, 2019
This content is from: Premium P. Schoenfeld Bets on Deals Event-driven specialist PSAM has sharply ramped up its exposure to merger investments. By Stephen Taub September 13, 2019
This content is from: Corner Office The Dirty Little Secret About Asset Manager Mergers Casey Quirk says that if done right, acquisitions can lead to lower costs and higher profitability — but they rarely go well. By Julie Segal July 17, 2019
This content is from: Premium Sandell Reminds Investors It’s Hard to Handicap Activists Many of the firm’s newest positions are merger arbitrage plays, not new activist targets. By Stephen Taub March 29, 2019
Sponsored Why Bond ETFs Will Continue to Grow The funds offer quick and efficient access to markets, and strategic flexibility, transforming fixed income investing. Sponsored by iShares February 24, 2020
Sponsored New Research: The Implications of Today’s Rapidly Evolving Business Models Sponsored by PGIM February 20, 2020
